Cargando…
Protection Induced by Plasmodium falciparum MSP1(42) Is Strain-Specific, Antigen and Adjuvant Dependent, and Correlates with Antibody Responses
Vaccination with Plasmodium falciparum MSP1(42)/complete Freund's adjuvant (FA) followed by MSP1(42)/incomplete FA is the only known regimen that protects Aotus nancymaae monkeys against infection by erythrocytic stage malaria parasites. The role of adjuvant is not defined; however complete FA...
Autores principales: | Lyon, Jeffrey A., Angov, Evelina, Fay, Michael P., Sullivan, JoAnn S., Girourd, Autumn S., Robinson, Sally J., Bergmann-Leitner, Elke S., Duncan, Elizabeth H., Darko, Christian A., Collins, William E., Long, Carole A., Barnwell, John W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474699/ https://www.ncbi.nlm.nih.gov/pubmed/18665258 http://dx.doi.org/10.1371/journal.pone.0002830 |
Ejemplares similares
-
MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of Plasmodium falciparum
por: Bergmann-Leitner, Elke S, et al.
Publicado: (2009) -
Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine
por: Bergmann-Leitner, Elke S, et al.
Publicado: (2012) -
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01
por: Otsyula, Nekoye, et al.
Publicado: (2013) -
Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy
por: Leitner, Wolfgang W, et al.
Publicado: (2010) -
Phase 1 Study of Two Merozoite Surface Protein 1 (MSP1(42)) Vaccines for Plasmodium falciparum Malaria
por: Malkin, Elissa, et al.
Publicado: (2007)